What insurance policy changes affect code N39.43?

There are 3 tracked policy changes affecting code N39.43, including updates from Independence Blue Cross, Blue Cross & Blue Shield of Mississippi. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code N39.43?

Payers that have issued tracked updates for code N39.43 include: Independence Blue Cross, Blue Cross & Blue Shield of Mississippi.

How do I get notified when code N39.43 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code N39.43. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code N39.43?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

PAYER POLICY CHANGES

N39.43 Insurance Policy Changes

ICD-10 N39.43 is officially defined as "Post-void dribbling." code N39.43 is referenced in 3 tracked payer policy changes from Independence Blue Cross and Blue Cross & Blue Shield of Mississippi. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code N39.43 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Independence Blue Cross · Effective Jan 1, 2026Medium impact
11.17.04z, Sacral Nerve Stimulation (SNS) and Posterior Tibial Nerve Stimulation (PTNS) for the Control of Incontinence
Independence Blue Cross reissued Policy 11.17.04z to add two new CPT codes (0988T and 0989T) as experimental/investigational effective 01/01/2026. These codes are excluded from coverage for all Independence Blue Cross products and are not eligible for reimbursement. The policy also reaffirms existing coverage criteria for sacral nerve stimulation (SNS) and posterior tibial nerve stimulation (PTNS) for incontinence treatment.
Blue Cross & Blue Shield of Mississippi · Identified Jun 20, 2026Medium impact
Injectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence
Carbon-coated spheres, calcium hydroxylapatite, polyacrylamide hydrogel, or polydimethylsiloxane may be considered medically necessary to treat stress urinary incontinence in men and women who have failed appropriate conservative therapy. Autologous cellular therapy, autologous fat, autologous ear chondrocytes, and any other periurethral bulking agent, including Teflon, are investigational for stress urinary incontinence. Periurethral bulking agents for urge urinary incontinence and perianal bulking agents for fecal incontinence are also investigational.
Independence Blue Cross · Effective Jan 1, 2026Low impact
MA11.028l, Sacral Nerve Stimulation (SNS) and Posterior Tibial Nerve Stimulation (PTNS) for the Control of Incontinence
Independence Blue Cross reissued MA11.028l on 01/21/2026 to communicate the company's continuing position on Sacral Nerve Stimulation (SNS) and Posterior Tibial Nerve Stimulation (PTNS) for incontinence control. Two new experimental/investigational CPT codes (0988T and 0989T) were added effective 01/01/2026 and are NOT covered. No changes to existing coverage criteria or medically necessary procedures.

Watch N39.43

Get one email when a payer policy names N39.43, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

11.17.04z, Sacral Nerve Stimulation (SNS) and Posterior Tibial Nerve Stimulation (PTNS) for the Control of Incontinence

Injectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence

MA11.028l, Sacral Nerve Stimulation (SNS) and Posterior Tibial Nerve Stimulation (PTNS) for the Control of Incontinence

What insurance policy changes affect code N39.43?

Which payers have updated policy for code N39.43?

How do I get notified when code N39.43 policy changes?

Why do payers change policies for code N39.43?